Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1

• Asıl Yazarlar: Huanhuan Hou (Yazar), Qisheng Peng (Yazar), Shaoming Wang (Yazar), Yuxin Zhang (Yazar), Jinjin Cao (Yazar), Yuming Deng (Yazar), Yingjian Wang (Yazar), Wan-chun Sun (Yazar), Hong-bing Wang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Osteoporosis is a metabolic bone disease characterized by insufficient osteoblastic function and/or excessive osteoclastic activity. One promising strategy for treating osteoporosis is inhibiting excessive osteoclast resorbing activity. Previous studies have revealed that anemonin (ANE), isolated fr...